Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4346-4351, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Detection of Intrastrain Antigenic Variation of Bacteroides
fragilis Surface Polysaccharides by Monoclonal Antibody
Labelling
Sheila
Patrick,*
Deirdre
Gilpin, and
Leanne
Stevenson
Department of Microbiology and Immunobiology,
School of Medicine, Queen's University of Belfast, Belfast BT12
6BN, United Kingdom
Received 16 February 1999/Returned for modification 30 March
1999/Accepted 15 June 1999
 |
ABSTRACT |
Bacteroides fragilis is a constituent of the normal
resident microbiota of the human intestine and is the gram-negative
obligately anaerobic bacterium most frequently isolated from clinical
infection. Surface polysaccharides are implicated as potential
virulence determinants. We present evidence of within strain
immunochemical variation of surface polysaccharides in populations that
are noncapsulate by light microscopy as determined by monoclonal
antibody labelling. Expression of individual epitopes can be enriched
from a population of an individual strain by use of immunomagnetic
beads. Also, individual colonies in which either >94% or <7% of the
bacteria carry an individual epitope retain this level of expression
when subcultured into broth. In broth cultures where >94% of the
bacteria carry a given epitope, there is no enrichment for other
epitopes recognized by different polysaccharide-specific monoclonal
antibodies. This intrastrain variation has important implications for
the development of potential vaccines or immunodiagnostic tests.
 |
INTRODUCTION |
Bacteroides fragilis is
the gram-negative strictly anaerobic bacterium most frequently isolated
from clinical infection. The major source of these infections is the
normal resident colonic microbiota, where Bacteroides spp.
outnumber facultatively anaerobic bacteria such as Escherichia
coli by a factor of between 102 and 103
(4). In the fecal microbiota, the predominant
Bacteroides spp. is B. vulgatus, with B. fragilis a relatively minor component. Namavar and colleagues
(6) report a relatively higher proportion of B. fragilis in the adherent mucosal microbiota; however, this was not
confirmed by Poxton and colleagues (19). It therefore appears that the frequency with which B. fragilis is
isolated from infection compared to other Bacteroides spp.
of the resident microbiota cannot be explained simply by weight of numbers.
The potential virulence determinants of B. fragilis have
been the subject of many investigations (9). It is clear
that a number of factors may contribute to the virulence of B. fragilis, including surface structures, release of extracellular
enzymes, iron-scavenging mechanisms, and enterotoxin production;
however, extracellular polysaccharides have been considered to play a
key role in B. fragilis virulence. Encapsulating structures
have been implicated in resistance to complement-mediated killing,
phagocytic uptake, and killing (21) and abscess formation in
an animal model (27). Many studies have failed to take into
account not only within-strain variation in capsule production but also
between- and within-strain antigenic variation of different types of
capsules. By electron microscopy, it is possible to identify within an
individual strain of B. fragilis bacteria with either large
or small capsules which are fibrous in appearance but are antigenically
different, as well as bacteria with an encapsulating electron-dense
layer (EDL) adjacent to the outer membrane (15, 16). The EDL
bacteria are noncapsulate by light microscopy, whereas the small and
large capsules are clearly visible with negative staining. Expression of the different capsular types is inheritable as populations can be
enriched by subculture from different interfaces of Percoll step
density gradients. Microscopical observation of the populations enriched for the three capsular types with monoclonal antibodies (MAbs)
specific for surface polysaccharides shows that noncapsulate bacteria
are antigenically different from bacteria with the small capsules but
have shared epitopes with large-capsule bacteria. In addition,
immunofluorescent and immunogold labelling for fluorescence and
electron microscopy, respectively, reveals antigenic variation in
populations which appear to be structurally homogeneous (5, 13,
22, 23). This phenomenon has been observed in recent clinical
isolates from a variety of anatomical sites, in isolates from different
geographical locations, and in culture collection type cultures
(17). By polyacrylamide gel electrophoresis (PAGE) and
immunoblotting with MAbs specific for surface polysaccharides, distinctive patterns are observed within the noncapsulate population of
an individual strain. These results indicate that an individual B. fragilis strain may produce a number of antigenically
different surface polysaccharides (5, 9, 10).
The aim of the present study was to investigate intrastrain variation
in B. fragilis populations which were homogeneous with respect to encapsulation. The stability of expression of individual polysaccharide epitopes within B. fragilis populations which
are noncapsulate by light microscopy (EDL enriched) was therefore examined.
We now report that populations already enriched for capsule type can
also be enriched for expression of individual surface polysaccharide epitopes in both broth and plate cultures.
 |
MATERIALS AND METHODS |
Bacterial strains and culture methods.
The strains used were
B. fragilis NCTC 9343 (National Collection of Type Cultures,
London, United Kingdom), LS66 and LS54 (clinical isolates from an
abdominal abscess and a perianal abscess respectively; Craigavon Area
Hospital, Northern Ireland, United Kingdom) (17), and JC17
(clinical isolate from an abscess; Belfast City Hospital, Northern
Ireland, United Kingdom). All strains were enriched on Percoll density
gradients for populations which were noncapsulate by light microscopy.
Bacteria were grown in defined minimal medium (DM) broth or on DM
plates (28) in an anaerobic cabinet (Mk. III anaerobic
cabinet; 80% N2, 10% CO2, and 10%
H2; Don Whitley Scientific, Shipley, United Kingdom). Identification was confirmed with the API20A (Biomérieux, Marcy L'Etoile, France) system.
Production and characterization of polyclonal antisera and
MAbs.
Polyclonal antiserum specific for B. fragilis
NCTC 9343 common antigen was produced as previously described
(17). Polyclonal antiserum specific for B. fragilis NCTC 9344 common antigen was the kind gift of I. Poxton,
University of Edinburgh. MAb production and initial characterization of
some of the MAbs are detailed in reference 5. MAb
QUBF 12 does not cross-react with E. coli but does
cross-react with Bacteroides thetaiotaomicron, B. vulgatus, and B. ovatus. The other MAbs do not
cross-react with E. coli, B. vulgatus, B. distasonis, B. ovatus, B. thetaiotaomicron,
or Porphyromonas gingivalis.
Where necessary, hybridoma culture supernatants were concentrated in
Vivaspin 15 concentrator filter units (Vivascience Ltd., Lincoln,
United Kingdom), and suitable working dilutions in 0.01 M
phosphate-buffered saline (PBS; 0.15 M NaCl, 0.0075 M
Na2HPO4, 0.0025 M
NaH2PO4 · 2H2O [pH 7.4])
were determined empirically. Sodium dodecyl sulfate-PAGE was performed
on vertical slab gels (8%), which were immunoblotted as previously
described (5), using a crude aqueous phenol extract prepared
as described by Poxton and Brown (18).
Separation and enrichment of bacterial populations.
Bacterial populations which were noncapsulate by light microscopy were
enriched by subculture from the 60 to 80% interface layer of Percoll
(Pharmacia, Uppsala, Sweden) discontinuous density gradients after
centrifugation as previously described (11). Encapsulation
was monitored by eosin-carbol fuchsin negative staining for light
microscopy (1). When required, these populations were
further enriched by using immunomagnetic beads as detailed below. Dynal
M-280 magnetic beads precoated with sheep anti-mouse immunoglobulin
[Dynal (UK) Ltd., Merseyside, United Kingdom] were used as described
by Patrick and Larkin (11). In brief, the beads were washed
by placing the tube containing the beads in a magnetic particle
concentrator and removing the PBS by pipette. Washed beads were
suspended in hybridoma culture supernatant containing the relevant
antibody, incubated at room temperature with gentle rocking for 24 h, and again washed in PBS. The following steps were all carried out
inside an anaerobic cabinet to ensure bacterial viability. The beads
were incubated with bacterial suspension (108 CFU/ml) in DM
plus 0.02% (vol/vol) Tween 20 (Sigma Chemical Co. Ltd., Poole, United
Kingdom) with gentle rocking for 2 min and washed three times in DM.
The beads were then inoculated into DM and incubated at 37°C in the
anaerobic cabinet until bacterial growth was visible.
Immunofluorescence microscopy.
Bacterial suspensions in PBS
were applied to multiwell microscope slides, dried at 37°C, and fixed
either in methanol at
20°C for 10 min or in paraformaldehyde (4%
[wt/vol] in 3× PBS [390 mM NaCl, 30 mM
Na2HPO4, 30 mM
NaH2PO4 · 2H2O {pH 7.2})
at 4°C for 30 min (20). For single labelling, the bacteria
were then reacted with a suitable dilution of concentrated mouse MAb
hybridoma supernatant followed by goat anti-mouse immunoglobulin G
(heavy and light chain) conjugated to fluorescein isothiocyanate (FITC; Sigma) as previously described (11). For dual labelling,
after incubation of the slides with MAb, they were washed, incubated with anti-B. fragilis common antigen polyclonal
rabbit antiserum (17), washed, and incubated with sheep
anti-rabbit FITC and goat anti-mouse tetramethyl rhodamine
isothiocyanate (TRITC; Sigma) before a final wash (11).
Slides were examined with a Leitz fluorescence microscope. An estimate
of the proportion of bacteria fluorescing was obtained either by
comparing FITC-labelled bacteria with bright-field phase-contrast view
or by comparing populations dual labelled with anti-rabbit polyclonal
antiserum and an anti-rabbit FITC conjugate and with mouse MAb and an
anti-mouse TRITC conjugate. All estimations of percentage labelling
involved counting a minimum of 100 bacterial cells per well.
Colony lifts and immunoreaction.
For colony lifts, total
viable counts were carried out after serial 10-fold dilution in
Ringer's solution (25% [wt/vol]) with cysteine (0.05%) and spread
plating onto DM agar. Unless stated otherwise, the plates were
incubated for 48 h. Plates with approximately 150 or fewer
colonies were chosen and processed as follows. Discs of nitrocellulose
(Millipore UK Ltd., Watford, United Kingdom) were gently applied to the
agar plate and lifted once the whole nitrocellulose disc appeared to be
wet. A maximum of three lifts were carried out on each plate. For
sterile lifts, the nitrocellulose discs were autoclaved prior to use.
The nitrocellulose discs were then air dried at room temperature
(approximately 22°C) under aerobic conditions for a minimum of 1 h, blocked with dried milk (5% [wt/vol]; Marvel, Chivers Ireland
Ltd., Dublin, Ireland) in PBS with Tween 20 (0.05%) for 1 h at
37°C, washed five times rapidly in PBS-Tween followed by five 5-min
washes, and either allowed to dry and stored at room temperature in
sealed polythene bags for later immunoreaction or used immediately. For
immunoreaction, the discs were incubated with the appropriate mouse MAb
diluted in PBS for 1 h at 37°C with gentle rocking and washed
rapidly five times in PBS-Tween followed by 5-min washes with gentle
rocking. The discs were then incubated for 1 h as described above
with goat anti-mouse alkaline phosphatase conjugate (Bio-Rad
Laboratories Ltd., Hemel Hempsted, United Kingdom). The discs were
washed as before except that the final wash was carried out in Tris
buffer (50 mM Tris HCl [pH 9.4]) prior to incubation in the substrate (Bio-Rad alkaline phosphatase substrate kit; p-nitroblue
tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate) according
to the manufacturer's instructions. Once the substrate color had reached sufficient intensity, the reaction was stopped by immersion in
distilled water and the nitrocellulose was blotted dry with filter
paper. Control reactions in which the MAb was replaced with PBS were
also processed. Colonies from the control reaction appeared light grey
in color, which may have been due to background bacterial alkaline
phosphatase activity; however, positive colonies were obviously bright
purple-blue. Positive colonies were counted and compared with the
initial colony count of the agar plate.
Protocol for determination of antigen expression in broth and
plate cultures.
For estimates of the proportion of bacteria
expressing an epitope in broth culture, four replicate 100-ml volumes
were inoculated and incubated at 37°C in the anaerobic cabinet until
they had reached an optical density at 600 nm of 0.3 (equivalent to
approximately 3 × 108 CFU/ml). The proportion of
bacteria within each broth which labelled with a given MAb was
estimated by immunofluorescence microscopic examination of 20 separate-microscope slide wells for each broth. A minimum of 100 bacteria were counted in each of the 20 wells.
A 10-fold dilution series was carried out for each of the replicate
broth cultures and three replicate spread plates prepared
for each
dilution. Three colony lifts were taken from each of
two replicate
spread plates for antibody reaction. Twenty colonies
were picked from
each of the remaining spread plates (80 colonies
in total), and the
number of bacteria which labelled with a given
MAb was estimated for
each colony by immunofluorescence microscopy.
Analyses of variance
indicated that there was no significant difference
between the
replicate broth cultures (95%
probability).
 |
RESULTS |
Epitope expression in broth culture.
Immunomagnetic bead
separation and broth enrichment with MAbs QUBF 6 and 7, specific for
high-molecular-mass polysaccharide with an associated fine ladder
pattern, and MAb QUBF 12, which recognizes an antigen similar in
molecular mass to the B. fragilis common antigen (Fig.
1), was successful as assessed by
immunofluorescence microscopy. The proportions of bacteria within a
population which expressed the various epitopes could be increased from
15 to 76% (QUBF 6), from 21 to 74%, (QUBF 7), and from 22 to 56%
(QUBF 12) with two subsequent immunomagnetic bead separations and
broth enrichments. The degree of enrichment obtained on different
occasions was not, however, always consistent. On a separate occasion,
the QUBF 6 epitope was increased only to 32% after two
enrichment steps.

View larger version (104K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblots of hot phenol-water extracts from B. fragilis NCTC 9343 after PAGE reacted with rabbit anti-B.
fragilis NCTC 9343 common antigen antiserum (track 1), rabbit
anti-B. fragilis NCTC 9344 common antigen antiserum (track
2), and MAbs QUBF 12 (track 3), QUBF 5 (track 4), QUBF 6 (track 5),
QUBF 7 (track 6), and QUBF 8 (track 7).
|
|
Stability of QUBF 6 and 7 epitope expression in B. fragilis noncapsulate populations.
The reactivity of MAbs
QUBF 6 and 7 which are specific for high-molecular-mass polysaccharide
with an associated fine ladder pattern was examined on pre- and
post-immunomagnetic bead-enriched cultures of B. fragilis
NCTC 9343. The proportion of bacteria labelling within replicate broth
cultures was determined by immunofluorescence microscopy, and the
proportion of colonies which labelled on spread plates prepared from
the broth cultures was determined by colony blotting. The proportion of
colonies which were positive was similar to that of the proportion of
individual bacterial cells positive by immunofluorescence microscopy in
the original broth culture (Table 1).
Similar results were obtained for three other strains of B. fragilis (Table 2), although the
proportion of bacteria that labelled was not the same for different
strains labelled with the same MAb. The failure to detect any positive
colonies by immunofluorescence microscopy after random selection of 20 colonies per plate, where it was estimated by colony lifts that 14% of
the colonies were positive, is probably due to the small sample size.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Reactivity of broth cultures and colonies of noncapsulate
B. fragilis NCTC 9343 with MAbs QUBF 6 and 7 before and
after immunomagnetic bead enrichment
|
|
The proportion of bacteria labelling within the individual colonies was
assessed by immunofluorescence and phase-contrast
microscopy. Either
94% or more of the cells in a colony were positive
by
immunofluorescence or less than 7% of the bacteria labelled
(Fig.
2 and Table
3). The proportion of colonies showing
94%
or greater labelling as estimated by immunofluorescence
microscopy,
scored as positive colonies, was comparable with the
proportion
of immunoreactive colonies on the nitrocellulose lifts and
in
the original broth culture (Table
1). To determine the relationship
between colonies positive by blotting and the proportion of the
population labelled by immunofluorescence microscopy, lifts were
carried out with sterile nitrocellulose and the plates were reincubated
for 24 h to allow the colonies to regrow. Colonies were then
picked
off and analyzed by immunofluorescence microscopy. Colonies with
94% or more bacteria positive by immunofluorescence were also
positive
by immunoblotting. Immunoblot-negative colonies related
to those with
7% or less of the populations labelling by immunofluorescence
microscopy.

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 2.
Light micrographs of B. fragilis NCTC 9343, prepared from single colonies, immunolabelled with both mouse MAb plus
anti-mouse TRITC conjugate and rabbit anti-B. fragilis
polyclonal antiserum plus anti-rabbit FITC conjugate viewed (100×
objective) with fluorescein filters (a) and the same field viewed with
rhodamine filters (b). (i) Colony labelled with MAb QUBF 6 in which
95% or more of the bacteria are labelled; (ii) another colony labelled
with MAb QUBF 6 in which only a small proportion of the total bacterial
population is labelled.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Proportion of bacteria within colonies, either positive
or negative by colony blotting, which label with MAbs QUBF 6 and 7 by immunofluorescence microscopy
|
|
Examination of the proportion of bacteria labelling in
immunoblot-negative colonies indicated that this was consistent in
the
four replicate broth cultures inoculated in parallel. The
proportion of
bacteria within these immunoblot-negative colonies
was, with the
exception of strain LS66, considerably less than
the proportion which
labelled in the original broth culture. An
increase in the length of
incubation of the colonies from 48 to
144 h and concomitant
increase in colony size did not increase
the proportion of the bacteria
within the colony which were labelled.
With the exception of strain
LS66, there was a clear difference
in the degree of labelling in
immunoblot-negative colonies between
QUBF 6 and QUBF 7. Continuous
daily subculture of colonies of
strain NCTC 9343 in DM broth for 5 days
resulted in a maintenance
of the level of expression of the epitopes at
either 94% or greater
or 7% or less for both QUBF 6 and QUBF
7.
Cross-reactivity of epitope-enriched populations with other
B. fragilis-specific MAbs.
Populations enriched using
immunomagnetic beads coated with either QUBF 6 (specific for
high-molecular-mass polysaccharide) or QUBF 12 (specific for a band
similar in molecular mass to the common antigen) and subcultured in DM
broth were examined for reactivity with other MAbs by
immunofluorescence microscopy (Table 4),
as were populations enriched by subculture of colonies immunoblot positive for QUBF 6 and 7 (specific for high-molecular-mass
polysaccharide) into DM broth (Table 5).
Reactivity of the enriched populations with MAbs showed that with none
of the MAbs tested was the proportion of bacteria labelled as great as
that labelled with the MAb for which the population had been enriched.
View this table:
[in this window]
[in a new window]
|
TABLE 4.
Reactivity of noncapsulate B. fragilis NCTC
9343 broth cultures with different MAbs after enrichment for epitope
expression by use of immunomagnetic beads
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Proportion of B. fragilis NCTC 9343 bacteria
in broth culture, derived from colonies positive for either QUBF 6 or 7 by colony blotting, which are MAb reactive by
immunofluorescence microscopy
|
|
QUBF 6 and 7 immunoblot-positive colonies were subcultured into DM
broth and examined for reactivity with QUBF 5 and other
MAbs specific
for high-molecular-mass polysaccharides (Table
5).
With the exception
of the reactivity of MAb QUBF 7 with QUBF 6-positive
cultures, only a
very small proportion of the bacteria
reacted.
 |
DISCUSSION |
The results clearly illustrate intrastrain antigenic variation of
the surface polysaccharides of B. fragilis. The epitopes recognized by the MAbs are present on distinct bacterial cells and are
detectable on highly variable proportions of bacterial cells within
individual natural populations as determined by immunofluorescence and
immunoelectron microscopy (9).
The results show conclusively that the proportion of bacterial cells
within a population which express these variable polysaccharides can be
enriched by using immunomagnetic beads coated with the relevant MAb,
followed by broth culture. The lack of reproducibility in the level of
enrichment obtained by using immunomagnetic beads on different
occasions was probably due to varying numbers of outer membrane
vesicles (14) attaching to the magnetic bead bound
antibodies and thus preventing bacterial attachment.
The proportion of bacteria which were labelled with MAbs QUBF 6 and 7, which both label polysaccharide in the high-molecular-mass region and
an associated fine ladder pattern, was different within the same
population of a given strain (Tables 1 and 2). For example, in two
strains 50% or more of the bacteria were labelled with MAb QUBF 7, but
very few or none of the cells labelled with MAb QUBF 6. This finding
suggests that although these polysaccharides appear to be
immunochemically similar after PAGE and immunoblotting, they are
antigenically different and that the number of bacteria within a
population which express these epitopes varies from strain to strain.
The level of expression of MAbs QUBF 6 and 7 within individual colonies
was, however, strikingly reproducible. Examination of individual
colonies, picked from an agar plate, showed either a high proportion
(>94%) or low proportion (<7%) of bacteria labelled for all the
strains examined. These proportions were maintained on subculture of
individual colonies into broth. This is similar to the phenomenon of
enrichment for expression of different capsule types after Percoll
density gradient centrifugation (9), which is also
maintained on subculture into broth. The relationship between the
number of colonies positive for a given epitope and the proportion of
bacteria that were labelled in the broth culture from which the
colonies were derived was also consistent. It is likely that colonies
with a low proportion of bacteria expressing the epitope were derived
from a cell which did not initially carry the epitope and that some
type of switching mechanism has generated the variants. The rate of
switching appeared to occur at a constant rate for the epitopes
examined, as the estimated level of expression remained constant for
different colonies and between experiments carried out at different
times. The proportion of bacteria expressing an epitope was maintained
when colonies were subcultured into broth continuously for up to 5 days. This finding suggests that either the switching mechanism
observed within the colonies does not function in the relatively
homogeneous environment of the broth culture or it occurs at a much
slower rate. Given the apparent constant rate of change in the
colonies, it is likely that there is an underlying genetic basis to the
mechanism that generates the variation. This is a well-documented
phenomenon in other pathogenic bacteria (24). It remains to
be determined if there is also an environmental influence on this type
of variation. Possibilities include external influences such as
nutrient availability or changes in the redox potential in the
microenvironment. Another possibility is that bacterial signalling
molecules such as for example the N-acyl homoserine lactones
(2) are involved. These have been well characterized in
other gram-negative bacteria, although to date no evidence has been
presented for the production of these or similar molecules in
Bacteroides spp. An environmental influence could perhaps
explain the differences observed between the colonies and the broth culture.
The lack of cross-reactivity of populations enriched from colonies in
which 98% or more labelled with a given MAb with other MAbs (Table 5)
suggests that enrichment for one polysaccharide epitope does not result
in coenrichment for a second epitope. Whether this represents exclusive
production of one antigenic type or the masking of one by another
remains to be determined. The patterns generated by PAGE and
immunoblotting, illustrated in Fig. 1, suggest that B. fragilis may express three distinct components extractable by
the hot phenol-water method. It is likely that these three components
are the smooth lipopolysaccharide (QUBF 5), high-molecular-mass
polysaccharide (QUBF 6 to 8), and common antigen (QUBF 12)
described by Poxton and Brown (18). Furthermore, the lack
of cross-reactivity of the populations enriched from QUBF 6- or
7-positive colonies with the other MAbs examined (Table 5) indicates
that there are at least three antigenic types of high-molecular-mass
polysaccharide with an associated ladder pattern. A further two MAbs,
which also did not cross-react with populations enriched from QUBF 6- or 7-positive colonies, have a PAGE pattern indicative of
high-molecular-mass polysaccharide but lacking the ladder pattern
(unpublished data).
The precise nature of the biochemical differences which generate these
different patterns of labelling are unknown. It is possible for
polysaccharides to be biochemically similar in terms of components
(e.g., sugar moieties) but for a wide variety of antigenic variation to
be generated by alteration of either the linkage of the substituent
moieties, their chemical substitution, or both. Antigenic variation
generated by these means is well documented in the polysaccharides of
other pathogenic bacteria such as Haemophilus influenzae,
E. coli, and Neisseria meningitidis (12). As yet, no chemical analyses have been carried out on the antigens described in this report. Their relationship with the
chemically characterized polysaccharides A and B described by Pantosti
and coauthors (7, 8) is therefore unknown. Polysaccharides A
and B were obtained from the fraction referred to as capsular polysaccharide (CP) by boiling in 5% acetic acid for 1 h. MAbs specific for either A or B revealed a broad high molecular mass band
after PAGE and immunoblotting of the CP fraction. After acetic acid
hydrolysis, a narrower band in the highest-molecular-mass region of the
broad band was visible for both fractions A and B and their respective
MAbs. It therefore appears that polysaccharides A and B also give a
similar pattern after PAGE and immunoblotting. A ladder pattern
associated with the broad band was detected in the CP fraction by using
polyclonal antiserum. These authors suggested that this ladder pattern
represented the ladder pattern described by ourselves in the small
capsule subpopulation enriched from strain NCTC 9343 by Percoll density
gradient centrifugation (23) and also the ladder pattern
interpreted by Poxton and Brown as a possible O antigen
(18). The ladder pattern illustrated by Poxton and Brown is
similar to that detected by our MAb QUBF 5 (Fig. 1) and has
wider-spaced bands than that illustrated by Pantosti and coauthors
(8). Their ladder pattern is, however, similar in appearance
to that observed in the small-capsule population (5,
23). As strain NCTC 9343 normally contains a mixture of
large-capsule, small-capsule, and noncapsulate bacteria, it is
likely that polysaccharides A and B were extracted from
a population with a mixture of types of capsule as well as
antigenic types.
The biological activity of our phenol-water extracts was not
investigated. Delahooke and coauthors (3), however, compared the immunomodulatory activity of polysaccharide material extracted from
B. fragilis by different methods and reported a high level of in vitro biological activity in phenol-water extracts. Material extracted from B. fragilis NCTC 9343 grown in the same
defined medium as we used (28) was 10 times more active in
the Limulus amoebocyte lysate assay than material obtained
from E. coli O18:K
. These authors acknowledge
that their B. fragilis extracts were probably heterogeneous
both in Mr and molecular composition. It would
be interesting to relate this biological activity to the potential
variety of components identified in the present study.
The capacity for antigenic variation could clearly be advantageous to
the survival of B. fragilis in both its pathogenic mode of
existence and in its role as a member of the normal intestinal microbiota. These results also have implications for any studies of the
virulence of B. fragilis and the chemical nature of these polysaccharides. Inter- and intrastain variation can be clearly observed not only in recent clinical isolates but also directly in pus
samples with MAb labelling and immunofluorescence microscopy (17,
25, 26). Studies of the immunological diversity of B. fragilis which rely only on whole-cell dot immunobinding or enzyme-linked immunosorbent assay (7) will not detect this within-strain diversity. The intrastrain variation will result in
titers in such assays which reflect the proportion of the bacteria within the population which are expressing the epitope. This
intrinsic variability of the surface polysaccharides will also
need to be taken into account in the production of potential
vaccines and immunodiagnostic tests based on polysaccharides.
In conclusion, surface polysaccharides of noncapsulate
B. fragilis are antigenically highly variable within
individual strains. Different antigenic types can be detected on
different bacterial cells within an individual population of a given
strain. The proportion of bacterial cells carrying any given epitope
will be variable depending on the strain and how it has been cultured
in the laboratory. Production of the same polysaccharide by all the
bacteria within a strain of B. fragilis is unlikely and
cannot be assumed.
 |
ACKNOWLEDGMENTS |
L.S. was in receipt of a European Social Fund grant.
We thank Lee McCallum for assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunobiology, School of Medicine, Queen's University of Belfast, Grosvenor Rd., Belfast BT12 6BN, United Kingdom. Phone: 44 (0)1232 240503. Fax: 44 (0)1232 439181. E-mail:
s.patrick{at}qub.ac.uk.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Cruickshank, R.
1965.
Medical microbiology: a guide to the laboratory diagnosis and control of infection, 11th ed., p. 657-660.
Churchill Livingstone, Edinburgh, United Kingdom.
|
| 2.
|
Davies, D. G.,
M. R. Parsek,
J. P. Pearson,
B. H. Iglewski,
J. W. Costerton, and E. P. Greenberg.
1998.
The involvement of cell-to-cell signals in the development of a bacterial biofilm.
Science
280:295-298[Abstract/Free Full Text].
|
| 3.
|
Delahooke, D. M.,
G. R. Barclay, and I. R. Poxton.
1995.
A re-appraisal of the biological activity of bacteroides LPS.
J. Med. Microbiol.
42:102-112[Abstract/Free Full Text].
|
| 4.
|
Duerden, B. I., and B. S. Drasar (ed.).
1991.
Anaerobes in human disease.
Edward Arnold, London, United Kingdom.
|
| 5.
|
Lutton, D. A.,
S. Patrick,
A. D. Crockard,
L. D. Stewart,
M. J. Larkin,
E. Dermott, and T. A. McNeill.
1991.
Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies.
J. Med. Microbiol.
35:229-237[Abstract/Free Full Text].
|
| 6.
|
Namavar, F.,
E. B. Theunissen,
A. M. J. J. Verweij-Van Vught,
P. G. Peerbooms,
M. Bal,
H. F. Hoitsma, and D. M. MacLaren.
1989.
Epidemiology of the Bacteroides fragilis group in the colonic flora of patients with colonic cancer.
J. Med. Microbiol.
29:171-176[Abstract/Free Full Text].
|
| 7.
|
Pantosti, A.,
R. Colangeli,
A. O. Tzianabos, and D. L. Kasper.
1995.
Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
J. Clin. Microbiol.
33:2647-2652[Abstract].
|
| 8.
|
Pantosti, A.,
A. O. Tzianabos,
A. B. Onderdonk, and D. L. Kasper.
1991.
Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.
Infect. Immun.
59:2075-2082[Abstract/Free Full Text].
|
| 9.
|
Patrick, S.
1993.
The virulence of Bacteroides fragilis.
Rev. Med. Microbiol.
4:40-49.
|
| 10.
|
Patrick, S.
1997.
Variation of Bacteroides fragilis surface structures, p. 19-30.
In
A. R. Eley, and K. W. Bennett (ed.), Anaerobic pathogens. Sheffield Academic Press, Sheffield, United Kingdom.
|
| 11.
|
Patrick, S., and M. J. Larkin.
1993.
Attachment in disease, p. 109-131.
In
S. P. Denyer, S. P. Gorman, and M. Sussman (ed.), Society for Applied Bacteriology Technical Series, 30. Microbial biofilms: formation and control. Blackwell Scientific Publications, Oxford, United Kingdom.
|
| 12.
|
Patrick, S., and M. J. Larkin.
1995.
Immunological and molecular aspects of bacterial virulence.
John Wiley & Sons, Chichester, United Kingdom.
|
| 13.
|
Patrick, S., and D. A. Lutton.
1990.
Bacteroides fragilis surface structure expression in relation to virulence.
Med. Mal. Infect.
20:19-25.
|
| 14.
|
Patrick, S.,
J. P. McKenna,
S. O'Hagan, and E. Dermott.
1996.
A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles.
Microb. Pathog.
20:191-202[Medline].
|
| 15.
|
Patrick, S., and J. H. Reid.
1983.
Separation of capsulate and non-capsulate Bacteroides fragilis on a discontinuous density gradient.
J. Med. Microbiol.
16:239-241[Abstract/Free Full Text].
|
| 16.
|
Patrick, S.,
J. H. Reid, and A. Coffey.
1986.
Capsulation of in vitro and in vivo grown Bacteroides species.
J. Gen. Microbiol.
132:1099-1109[Abstract/Free Full Text].
|
| 17.
|
Patrick, S.,
L. D. Stewart,
N. Damani,
K. G. Wilson,
D. A. Lutton,
M. J. Larkin,
I. Poxton, and R. Brown.
1995.
Immunological detection of Bacteroides fragilis in clinical samples.
J. Med. Microbiol.
43:99-109[Abstract/Free Full Text].
|
| 18.
|
Poxton, I. R., and R. Brown.
1986.
Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen.
J. Gen. Microbiol.
132:2475-2481[Abstract/Free Full Text].
|
| 19.
|
Poxton, I. R.,
R. Brown,
A. Sawyerr, and A. Ferguson.
1997.
Mucosa-associated bacterial flora of the human colon.
J. Med. Microbiol.
46:85-91[Abstract/Free Full Text].
|
| 20.
|
Ramage, G.,
S. Patrick, and S. Housto .
1998.
Combined fluorescent in situ hybridisation and immunolabelling of Bacteroides fragilis.
J. Immunol. Methods
212:139-147[Medline].
|
| 21.
|
Reid, J. H., and S. Patrick.
1984.
Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
J. Med. Microbiol.
17:247-257[Abstract/Free Full Text].
|
| 22.
|
Reid, J. H.,
S. Patrick,
E. Dermott,
A. Trudgett, and S. Tabaqchali.
1985.
Investigation of antigenic expression of Bacteroides fragilis by immunogold labelling and immunoblotting with a monoclonal antibody.
FEMS Microbiol. Lett.
30:289-293.
|
| 23.
|
Reid, J. H.,
S. Patrick, and S. Tabaqchali.
1987.
Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM-monoclonal antibody.
J. Gen. Microbiol.
133:171-179[Abstract/Free Full Text].
|
| 24.
|
Seifert, H., and M. So.
1988.
Genetic mechanisms of bacterial antigenic variation.
Microbiol. Rev.
52:327-336[Free Full Text].
|
| 25.
|
Stewart, L. D.
1993.
Ph.D. thesis.
Queen's University of Belfast, Belfast, United Kingdom.
|
| 26.
|
Stewart, L. D.,
S. Patrick,
D. A. Lutton,
M. J. Larkin,
I. R. Poxton, and R. Brown.
1992.
Immunological detection of polysaccharide antigens of Bacteroides fragilis in human pus samples, p. 55-56.
In
B. I. Duerden, J. S. Brazier, S. V. Seddon, and W. G. Wade (ed.), Medical and environmental aspects of anaerobes. Wrightson Biomedical Publishing Ltd., Petersfield, United Kingdom.
|
| 27.
|
Tzianabos, A. O.,
A. B. Onderdonk,
B. Rosner,
R. L. Cisneros, and D. L. Kasper.
1993.
Structural features of polysaccharides that induce intra-abdominal abscesses.
Science
262:416-419[Abstract/Free Full Text].
|
| 28.
|
van Tassell, R. L., and T. D. Wilkins.
1978.
Isolation of auxotrophs of Bacteroides fragilis.
Can. J. Microbiol.
24:1619-1621[Medline].
|
Infection and Immunity, September 1999, p. 4346-4351, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Alhawi, M., Stewart, J., Erridge, C., Patrick, S., Poxton, I. R.
(2009). Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. J Med Microbiol
58: 1015-1022
[Abstract]
[Full Text]
-
Wexler, H. M.
(2007). Bacteroides: the Good, the Bad, and the Nitty-Gritty. Clin. Microbiol. Rev.
20: 593-621
[Abstract]
[Full Text]
-
Cerdeno-Tarraga, A. M., Patrick, S., Crossman, L. C., Blakely, G., Abratt, V., Lennard, N., Poxton, I., Duerden, B., Harris, B., Quail, M. A., Barron, A., Clark, L., Corton, C., Doggett, J., Holden, M. T. G., Larke, N., Line, A., Lord, A., Norbertczak, H., Ormond, D., Price, C., Rabbinowitsch, E., Woodward, J., Barrell, B., Parkhill, J.
(2005). Extensive DNA Inversions in the B. fragilis Genome Control Variable Gene Expression. Science
307: 1463-1465
[Abstract]
[Full Text]
-
Patrick, S., Parkhill, J., McCoy, L. J., Lennard, N., Larkin, M. J., Collins, M., Sczaniecka, M., Blakely, G.
(2003). Multiple inverted DNA repeats of Bacteroides fragilis that control polysaccharide antigenic variation are similar to the hin region inverted repeats of Salmonella typhimurium. Microbiology
149: 915-924
[Abstract]
[Full Text]